345 related articles for article (PubMed ID: 28267535)
1. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
2. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
[TBL] [Abstract][Full Text] [Related]
3. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
4. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
[TBL] [Abstract][Full Text] [Related]
5. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor.
Ishimaru H; Nakashima K; Sakugawa T; Sakamoto A; Matsuoka Y; Ashizawa K; Uetani M
AJR Am J Roentgenol; 2014 Apr; 202(4):744-51. PubMed ID: 24660701
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE.
Hu B; Zhong BY; Zhang L; Dai C; Li W; Shen J; Huang P; Zhang S; Li Z; Ni CF
Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1460-1467. PubMed ID: 32500251
[TBL] [Abstract][Full Text] [Related]
7. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
[TBL] [Abstract][Full Text] [Related]
8. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
9. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
10. Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging.
Byun J; Kim SY; Kim JH; Kim MJ; Yoo C; Shim JH; Lee SS
Acta Radiol; 2021 Dec; 62(12):1548-1558. PubMed ID: 33197329
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
13. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.
Dioguardi Burgio M; Sartoris R; Libotean C; Zappa M; Sibert A; Vilgrain V; Ronot M
Cancer Imaging; 2019 Nov; 19(1):75. PubMed ID: 31730491
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI.
Kubota K; Hisa N; Nishikawa T; Fujiwara Y; Murata Y; Itoh S; Yoshida D; Yoshida S
Abdom Imaging; 2001; 26(2):184-90. PubMed ID: 11178697
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
[TBL] [Abstract][Full Text] [Related]
17. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
